Approximately, 240,000 men in the U.S. are diagnosed with prostate cancer annually [1]. The majority of these cases represent low-risk, organ-confined disease for which targeted therapy has emerged as a treatment alternative that spares patients from undesired side effects such as impotence and incontinence [2]. Focal laser ablation (FLA) utilizes a diode laser catheter to generate a well-controlled ablation zone, causing rapid heating of targeted cancerous tissue, and leaving the majority of the surrounding gland intact. While FLA for localized prostate cancer is receiving increased attention due to its minimally invasive nature, the procedure has several technical limitations. Most notable are the difficulty of (1) effectively localizing the prostate tumor according to the treatment planning, (2) safely placing the laser catheter to ablate the entire tumor and achieve adequate margins, and (3) accurately monitoring the ablated area. Larger tumors require multiple...

References

References
1.
Siegel
,
R.
,
Ma
,
J.
,
Zou
,
Z.
, and
Jemal
,
A.
,
2014
, “
Cancer Statistics, 2014
,”
CA-Cancer J. Clin.
,
64
(
1
), pp.
9
29
.
2.
Raz
,
O.
,
Haider
,
M. A.
,
Davidson
,
S. R.
,
Lindner
,
U.
,
Hlasny
,
E.
,
Weersink
,
R.
,
Gertner
,
M. R.
,
Kucharcyzk
,
W.
,
McCluskey
,
S. A.
, and
Trachtenberg
,
J.
,
2010
, “
Real-Time Magnetic Resonance Imaging-Guided Focal Laser Therapy in Patients With Low-Risk Prostate Cancer
,”
Eur. Urol.
,
58
(
1
), pp.
173
177
.
3.
Xu
,
S.
,
Kruecker
,
J.
,
Amalou
,
H.
,
Kwak
,
J. T.
, and
Wood
,
B. J.
,
2014
, “
Real-Time Treatment Iterative Planning for Composite Ablations
,”
Computer Assisted Radiology and Surgery 28th International Congress and Exhibition
(CARS 2014), Fukuoka, Japan, June 25–28, pp. 52–53.
You do not currently have access to this content.